Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma

Clinical trial NCT07057596 · RECRUITING

Trial details

NCT number: NCT07057596
Sponsor: Grupo Español Multidisciplinar de Melanoma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mestastatic Uveal Melanoma

Start date: 2025-07-18
Primary completion: 2027-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.